Last reviewed · How we verify

NCT04879251: ICOVdia

The Impact of the COVID-19 Pandemic on Cardiovascular Risk Factors in Patients With Diabetes

Completed Last updated 7 December 2022
What this trial tests

trial testing No intervention in Diabetes Mellitus in 1,000 participants. Completed in 31 August 2022.

Timeline
26 April 2021
Primary endpoint
31 August 2022
31 August 2022

Quick facts

Lead sponsorUniversity Hospital Ostrava
StatusCompleted
Study typeOBSERVATIONAL
Enrollment1,000
Start date26 April 2021
Primary completion31 August 2022
Estimated completion31 August 2022
Sites1 location across Czechia

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital Ostrava

Who can join

18 and older, any sex, with Diabetes Mellitus or Covid19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to compare cardiovascular risk factors in patients with diabetes before the start of the pandemic of the COVID 19 (time 1 - T1), after 1 year (time 2 - T2) and 2 years (time 3 - T3) duration. In patients with all types of diabetes, the investigators will compare the value of blood pressure, LDL cholesterol, BMI (body mass index) and glycated haemoglobin in T1, T2 and T3 during outpatient control.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Interaction between endothelial injury and immune response in septic shock: from basic research to clinical applications.
    Wang Y, Guan QN, Zhang ZJ, Zhang YM. · · 2025 · PMID 40980807 · DOI 10.3389/fphys.2025.1627008

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other recruiting trials for Diabetes Mellitus

Currently open trials in the same condition.

Other University Hospital Ostrava trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04879251.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing